Deep brain stimulation for Parkinson's disease: Thinking about the long-term in the short-term

Movement Disorders

Volumn 26, Issue 13, 2011, Pages 2303-2304

  Obeso, Jose A ^a   Olanow, Warren ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; NORADRENALIN; SEROTONIN;

AUTONOMIC NERVOUS SYSTEM; BODY POSTURE; BRAIN DEPTH STIMULATION; BRAIN STEM; COGNITIVE DEFECT; COMORBIDITY; DAILY LIFE ACTIVITY; DEMENTIA; DISABILITY; DISEASE COURSE; DOPAMINERGIC NERVE CELL; EDITORIAL; EMOTIONAL DISORDER; FALLING; FOLLOW UP; GAIT DISORDER; HEMISPHERE; HUMAN; LEWY BODY; LOCUS CERULEUS; MEYNERT BASAL NUCLEUS; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; RAPHE MAGNUS NUCLEUS; SPEECH DISORDER; SPINAL CORD; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; TREMOR;

DEEP BRAIN STIMULATION; FEMALE; HUMANS; MALE; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 82055172709     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24036     Document Type: Editorial

References (11)

1. Obeso JA, Olanow CW, Rodriguez-Oroz MC, et al. The Deep Brain Stimulation for Advanced Parkinson Disease Study Group. Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345: 956-963.
2. Deuschl G, Schade-Brittinger C, Krack P, et al A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
3. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301: 63-73.
4. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077-2091.
5. Hariz M. Surgical probings into the basal ganglia: hemorrhage and hardware-related risks, and costs of microelectrode recording. Mov Disord 2011;26:1375-1377.
6. Antonini A, Isaias IU, Rodolfi G, Landi et al A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol 2011; 258: 579-585.
7. Zibetti M, Merola A, Rizzi L, et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's Disease. Mov Disord 2011; 26: 2327-2334.
8. Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010; 133: 2664-2676.
9. Rodriguez-Oroz MC, Obeso JA, Lang AE. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128): 2240-2249.
10. Rodríguez MC, Obeso JA, Olanow CW. The subthalamo-nigral pathway in Parkinson's disease: a possible target for neuroprotection. Ann. Neurol 1998; 44( Suppl 1): 175-188.
11. Kahn E, D'Haese PF, Dawant B, et al. Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry 2011 (in press).